Summary: Centessa Pharmaceuticals has presented preclinical data on ORX142, an investigational orexin receptor 2 (OX2R) agonist, during the 27th Congress of the European Sleep Research Society. ORX142 demonstrated significant wake-promoting effects in non-human primates at very … [Read more...]